Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bcce67603bb6ab52eb827b7bae4f5db3d> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bcce67603bb6ab52eb827b7bae4f5db3d NCIT_P378 "NCI" @default.
- Bcce67603bb6ab52eb827b7bae4f5db3d type Axiom @default.
- Bcce67603bb6ab52eb827b7bae4f5db3d annotatedProperty IAO_0000115 @default.
- Bcce67603bb6ab52eb827b7bae4f5db3d annotatedSource NCIT_C101259 @default.
- Bcce67603bb6ab52eb827b7bae4f5db3d annotatedTarget "A pegylated, recombinant form of L-asparaginase derived from the bacterium Erwinia chrysanthemi (mPEG-R-Crisantaspase), with potential antineoplastic activity. Upon intravenous administration of pegylated recombinant L-asparaginase Erwinia chrysanthemi, asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting cancer cells of asparagine thus blocking protein synthesis and tumor cell proliferation. Asparagine is critical to protein synthesis in cancer cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. Compared to other available Erwinia chrysanthemi derived L-asparaginase agents, the pegylated form is longer acting and less immunogenic." @default.